Vitamin A and systemic inflammation as protective factors in multiple sclerosis

Multiple Sclerosis Journal

Volumn 19, Issue 8, 2013, Pages 1046-1051

  Salzer, Jonatan ^a   Hallmans, Göran ^a   Nyström, Maria ^a   Stenlund, Hans ^a   Wadell, Göran ^a   Sundström, Peter ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

c reactive protein; case control study; CRP; hygiene hypothesis; Multiple sclerosis; retinol; risk factors in epidemiology; vitamin a

Indexed keywords

C REACTIVE PROTEIN; RETINOL; RETINOL BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; INFANT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREGNANCY; PRESCHOOL CHILD; PROGENY; SCHOOL CHILD;

EID: 84879759597     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512472752     Document Type: Article

References (33)

1. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 ; 476: 214-219
2. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007 ; 61: 288-299 (Pubitemid 46676728)
3. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007 ; 61: 504-513 (Pubitemid 47068132)
4. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 ; 296: 2832-2838 (Pubitemid 44969183)
5. Salzer J, Hallmans G, Nyström M, et al. Vitamin D as a protective factor in multiple sclerosis. Neurology. 2012 ; 79: 2140-2145
6. Sommer A. Vitamin A deficiency and clinical disease: An historical overview. J Nutr. 2008 ; 138: 1835-1839
7. Racke MK, Burnett D, Pak SH, et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol. 1995 ; 154: 450-458
8. Global prevalence of vitamin A deficiency in populations at risk 1995-2005. WHO Global Database on Vitamin A Deficiency. Geneva: World Health Organization ; 2009:
9. Ganrot PO, Grubb A, Lindstedt G, et al Clinical chemistry in practical medicine (in Swedish). Nilsson-Ehle P, ed. Studentlitteratur ; 2003: 637-642.
10. Engedal N. Immune regulator vitamin A and T cell death. Vitam Horm. 2011 ; 86: 153-178
11. Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr. 2001 ; 21: 167-192 (Pubitemid 32695269)
12. Sista ND, Pagano JS, Liao W, et al. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc Natl Acad Sci U S A. 1993 ; 90: 3894-3898 (Pubitemid 23134132)
13. Lin JC, Smith MC, Pagano JS. Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retinoic acid and 9-(2-hydroxyethoxymethyl) guanine. Virology. 1981 ; 111: 294-298 (Pubitemid 11047700)
14. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat Rev Immunol. 2008 ; 8: 685-698
15. Jimenez-Lara AM, Aranda A. Interaction of vitamin D and retinoid receptors on regulation of gene expression. Horm Res. 2000 ; 54: 301-305 (Pubitemid 34701738)
16. Thompson PD, Jurutka PW, Haussler CA, et al. Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. J Biol Chem. 1998 ; 273: 8483-8491 (Pubitemid 28168913)
17. Willer CJ, Dyment DA, Sadovnick AD, et al. Timing of birth and risk of multiple sclerosis: Population based study. BMJ. 2005 ; 330: 120-124
18. Baeten JM, Richardson BA, Bankson DD, et al. Use of serum retinol-binding protein for prediction of vitamin A deficiency: Effects of HIV-1 infection, protein malnutrition, and the acute phase response. Am J Clin Nutr. 2004 ; 79: 218-225 (Pubitemid 41095973)
19. Salzer J, Hallmans G, Nyström M, et al. Smoking as a risk factor for multiple sclerosis. Mult Scler. 2012 ;:
20. Loken-Amsrud KI, Myhr KM, Bakke SJ, et al. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult Scler. 2012 ;:
21. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004 ; 62: 60-65 (Pubitemid 38082871)
22. Michaelsson K, Lithell H, Vessby B, et al. Serum retinol levels and the risk of fracture. N Engl J Med. 2003 ; 348: 287-294 (Pubitemid 36119983)
23. Fleming JO, Cook TD. Multiple sclerosis and the hygiene hypothesis. Neurology. 2006 ; 67: 2085-2086 (Pubitemid 44967402)
24. Okada H, Kuhn C, Feillet H, et al. The 'hygiene hypothesis' for autoimmune and allergic diseases: An update. Clin Exp Immunol. 2010 ; 160: 1-9
25. Simanek AM, Dowd JB, Pawelec G, et al. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One. 2011 ; 6: e16103
26. Bartlett DB, Firth CM, Phillips AC, et al. The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell. 2012 ; 11: 912-915
27. Waubant E, Mowry EM, Krupp L, et al. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 2011 ; 76: 1989-1995
28. SundqvistEBergströmTDaialhoseinH. Cytomegalovirus seropositivity is associated with lower multiple sclerosis risk. ECTRIMS presentation2012.
29. Sundstrom P, Juto P, Wadell G, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study. Neurology. 2004 ; 62: 2277-2282 (Pubitemid 38787787)
30. Mossberg N, Movitz C, Hellstrand K, et al. Oxygen radical production in leukocytes and disease severity in multiple sclerosis. J Neuroimmunol. 2009 ; 213: 131-134
31. Tsuriya D, Morita H, Morioka T, et al. Significant correlation between visceral adiposity and high-sensitivity c-reactive protein (hs-CRP) in Japanese subjects. Intern Med. 2011 ; 50: 2767-2773
32. Eliasson M, Lindahl B, Lundberg V, et al. Diabetes and obesity in Northern Sweden: Occurrence and risk factors for stroke and myocardial infarction. Scand J Public Health Suppl. 2003 ; 61: 70-77
33. Kindmark CO. The concentration of C-reactive protein in sera from healthy individuals. Scand J Clin Lab Invest. 1972 ; 29: 407-411